Jim Simons's position in Novartis AG is currently worth $294 Million. That's 0.45% of their equity portfolio (34th largest holding). The first Novartis AG trade was made in Q3 2013. Since then Jim Simons bought shares 26 more times and sold shares on nineteen occasions. The stake costed the investor $221 Million, netting the investor a gain of 33% so far.